Anna Chorzalska

624 total citations
40 papers, 410 citations indexed

About

Anna Chorzalska is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Anna Chorzalska has authored 40 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Genetics and 11 papers in Hematology. Recurrent topics in Anna Chorzalska's work include Erythrocyte Function and Pathophysiology (11 papers), Blood properties and coagulation (8 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Anna Chorzalska is often cited by papers focused on Erythrocyte Function and Pathophysiology (11 papers), Blood properties and coagulation (8 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Anna Chorzalska collaborates with scholars based in United States, Poland and Germany. Anna Chorzalska's co-authors include Patrycja M. Dubielecka, Aleksander F. Sikorski, Witold Diakowski, Ewa Bok, Anita Hryniewicz‐Jankowska, Michał Grzybek, Olin D. Liang, Aleksander Czogalla, Janet A. Sawicki and Adam J. Olszewski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Anna Chorzalska

34 papers receiving 404 citations

Peers

Anna Chorzalska
Kiyoharu Ito Japan
Rahel Mathew United States
Mary E. Olanich United States
Maurice Reimann Germany
Byung–Kyu Ryu South Korea
Órla T. Cox Ireland
T.A. Deisher United States
Ryan A. Denu United States
Olubunmi Afonja United States
JulieAnn Rader United States
Kiyoharu Ito Japan
Anna Chorzalska
Citations per year, relative to Anna Chorzalska Anna Chorzalska (= 1×) peers Kiyoharu Ito

Countries citing papers authored by Anna Chorzalska

Since Specialization
Citations

This map shows the geographic impact of Anna Chorzalska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Chorzalska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Chorzalska more than expected).

Fields of papers citing papers by Anna Chorzalska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Chorzalska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Chorzalska. The network helps show where Anna Chorzalska may publish in the future.

Co-authorship network of co-authors of Anna Chorzalska

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Chorzalska. A scholar is included among the top collaborators of Anna Chorzalska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Chorzalska. Anna Chorzalska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chorzalska, Anna, James P. Morgan, Nagib Ahsan, et al.. (2023). Proximity proteomics reveals role of Abelson interactor 1 in the regulation of TAK1 / RIPK1 signaling. Molecular Oncology. 17(11). 2356–2379. 2 indexed citations
3.
Nguyen, Lisa, et al.. (2023). NF-κB signaling in neoplastic transition from epithelial to mesenchymal phenotype. Cell Communication and Signaling. 21(1). 291–291. 47 indexed citations
4.
Olszewski, Adam J., Thomas Ollila, Ari Pelcovits, et al.. (2023). Alterations in Immune Cell Composition during First-Line Therapy with Mosunetuzumab for Follicular or Marginal Zone Lymphoma. Blood. 142(Supplement 1). 1651–1651.
5.
Wilson, Zachary, et al.. (2022). Engraftment, Fate, and Function of HoxB8-Conditional Neutrophil Progenitors in the Unconditioned Murine Host. Frontiers in Cell and Developmental Biology. 10. 840894–840894. 5 indexed citations
6.
Fast, Loren D., et al.. (2021). Murine Leukemia-Derived Extracellular Vesicles Elicit Antitumor Immune Response. Journal of Blood Medicine. Volume 12. 277–285. 4 indexed citations
7.
Olszewski, Adam J., Anna Chorzalska, Diana O. Treaba, et al.. (2019). Tumor-Specific Cell-Free DNA (cfDNA) in the Cerebrospinal Fluid (CSF) Detects Cytologically Occult Central Nervous System (CNS) Involvement in Aggressive Lymphomas. Blood. 134(Supplement_1). 2800–2800. 1 indexed citations
8.
Olszewski, Adam J., Anna Chorzalska, Annette S. Kim, et al.. (2018). Recipients of Myelotoxic Chemotherapy Have Increased Prevalence of Clonal Hematopoiesis of Indeterminate Potential (CHIP) with a Typical Distribution of Chip-Associated Mutations. Blood. 132(Supplement 1). 3841–3841. 2 indexed citations
9.
Chorzalska, Anna, Nagib Ahsan, Alexander Tepper, et al.. (2017). Map3k8/COT1/Tpl2 Drives Resistance to Bcr-Abl1 Inhibition through Activation of MEK-ERK and NF-Kb Pathways. Blood. 130. 2529–2529. 1 indexed citations
10.
Chorzalska, Anna, Karim Roder, Alexander Tepper, et al.. (2017). Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia. Stem Cells and Development. 26(9). 656–677. 18 indexed citations
11.
Chorzalska, Anna, Saad M. Khan, Diana O. Treaba, et al.. (2014). Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia. Leukemia. 28(11). 2165–2177. 11 indexed citations
12.
Chorzalska, Anna & Patrycja M. Dubielecka. (2014). New Abelson interactor-1 (Abi-1)-driven mechanism of acquired drug resistance. PubMed. 3(S1). S7–S8. 1 indexed citations
13.
Xiong, Xiufang, Anna Chorzalska, Patrycja M. Dubielecka, et al.. (2012). Disruption of Abi1/Hssh3bp1 expression induces prostatic intraepithelial neoplasia in the conditional Abi1/Hssh3bp1 KO mice. Oncogenesis. 1(9). e26–e26. 16 indexed citations
14.
Wolny, Marcin, Michał Grzybek, Ewa Bok, et al.. (2011). Key Amino Acid Residues of Ankyrin-Sensitive Phosphatidylethanolamine/Phosphatidylcholine-Lipid Binding Site of βI-Spectrin. PLoS ONE. 6(6). e21538–e21538. 19 indexed citations
15.
Chorzalska, Anna, Tomasz Borowik, Marcin Wolny, et al.. (2010). The effect of the lipid-binding site of the ankyrin-binding domain of erythroid β-spectrin on the properties of natural membranes and skeletal structures. Cellular & Molecular Biology Letters. 15(3). 406–23. 12 indexed citations
16.
Chorzalska, Anna, et al.. (2009). Fluorescence approach to evaluating conformational changes upon binding of β-spectrin ankyrin-binding domain mutants with the lipid bilayer. General Physiology and Biophysics. 28(3). 283–293. 2 indexed citations
17.
Grzybek, Michał, et al.. (2008). The 22.5kDa spectrin-binding domain of ankyrinR binds spectrin with high affinity and changes the spectrin distribution in cells in vivo. Protein Expression and Purification. 60(2). 157–164. 9 indexed citations
18.
Bok, Ewa, Anita Hryniewicz‐Jankowska, Anna Chorzalska, et al.. (2007). Lipid‐binding role of βII‐spectrin ankyrin‐binding domain. Cell Biology International. 31(12). 1482–1494. 12 indexed citations
19.
Bogusławska, Dżamila M., et al.. (2003). Hereditary spherocytosis: identification of several HS families with ankyrin and band 3 deficiency in a population of southwestern Poland. Annals of Hematology. 83(1). 28–33. 10 indexed citations
20.
Bogusławska, Dżamila M., Elżbieta Heger, Anna Chorzalska, et al.. (2002). Identification of several families with hereditary spherocytosis in a population from South-Western Poland. Cellular & Molecular Biology Letters. 7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kiyoharu Ito Breakdown of academic impact, for papers by Rahel Mathew Breakdown of academic impact, for papers by Mary E. Olanich Breakdown of academic impact, for papers by Maurice Reimann Breakdown of academic impact, for papers by Byung–Kyu Ryu Breakdown of academic impact, for papers by Órla T. Cox Breakdown of academic impact, for papers by T.A. Deisher Breakdown of academic impact, for papers by Ryan A. Denu Breakdown of academic impact, for papers by Olubunmi Afonja Breakdown of academic impact, for papers by JulieAnn Rader
Rankless by CCL
2026